{
    "eid": "2-s2.0-85092484514",
    "title": "Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years",
    "cover-date": "2020-11-10",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antibody",
        "Enterovirus-A71",
        "Longitudinal study",
        "Neutralizing antibody"
    ],
    "authors": [
        "Jiratchaya Puenpa",
        "Jira Chansaenroj",
        "Chompoonut Auphimai",
        "Donchida Srimuan",
        "Thaksaporn Thatsanathorn",
        "Yong Poovorawan",
        "Nasamon Wanlapakorn"
    ],
    "citedby-count": 1,
    "ref-count": 42,
    "ref-list": [
        "Virology, epidemiology, pathogenesis, and control of enterovirus 71",
        "Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity",
        "Genetic diversity of enterovirus A71",
        "Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017",
        "Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak",
        "An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang City of China",
        "Enterovirus 71 outbreak in the People's Republic of China in 2008",
        "An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong",
        "Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia",
        "First isolation and genomic characterization of enterovirus A71 and coxsackievirus A16 from hand foot and mouth disease patients in the Lao PDR",
        "The history of Enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific Region",
        "Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012",
        "Enterovirus A71 Infection, Thailand, 2017",
        "An inactivated enterovirus 71 vaccine in healthy children",
        "Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China",
        "Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial",
        "Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing",
        "A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine",
        "Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers",
        "An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages",
        "Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand",
        "Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations",
        "Seroepidemiology of human enterovirus 71, Singapore",
        "Enterovirus 71 maternal antibodies in infants, Taiwan",
        "Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women",
        "Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: A randomized trial",
        "Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study",
        "Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies",
        "Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants",
        "Seroprevalence of Enterovirus 71 antibody among children in China: a systematic review and meta-analysis",
        "Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city",
        "Enterovirus 71 seroepidemiology in Taiwan in 2017 and comparison of those rates in 1997, 1999 and 2007",
        "Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia",
        "Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany",
        "Enterovirus 71 neutralizing antibodies seroepidemiological research among children in Guangzhou, China between 2014 and 2015: A cross-sectional study",
        "Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam",
        "Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases",
        "Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial",
        "An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group",
        "Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Biostatistics Excellence Centre, Faculty of Medicine, Chulalongkorn University",
        "Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn Universiy",
        "Ratchadaphiseksomphot Endowment Fund",
        "Thrasher Research Fund",
        "National Research Council of Thailand",
        "Faculty of Medicine, Chulalongkorn University",
        "MIPH"
    ]
}